Form D · Venture Capital Fund
HCC ReferWell Coinvest, LLC
New York, NY · CIK 0002160100
Offering snapshot reported Oct 15, 2026 · SEC filing
- Reported sold
- $1.61M Indefinite offering
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 28, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 15, 2026 | Initial | $1,611,894 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-601308
Source: Form D, filed Oct 15, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charles Boorady | Executive |
| N/A Health Catalyst Capital Management, Llc | Director |
| Paula Semelmacher | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
515 Madison Avenue, 27 Th Floor
New York, NY, 10022
New York, NY, 10022